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If the genetic probability had not been 1 to 1 but 3 to 1 against the woman being a heterozygote, then enzyme levels of 1.5 units and 2.5 units would give, respectively, combined relative probabilities of about 30 to 1 against and about 3 to 1 in favour of her being a heterozygote. A young woman taken at random from the population and with no relative with muscular dystrophy would have a genetic probability of only about 1 in 5,000 of being a carrier. So even if her enzyme level was 2.5 units, the total relative probability would still be about 500 to 1 against her being a carrier.
The number of women heterozygous for the genes for the mild sex-linked and autosomal recessive types who have been tested for creatine kinase levels is too small to establish reliable means and ranges. However, it is interesting that, though the mild sex-linked variety is clinically less severe than the autosomal recessive form, the enzyme levels of the carriers of the gene for the sex-linked form do not differ significantly from the levels in the carriers of the severe sex-linked form ; while levels in the carriers of the gene for the autosomal form do not differ significantly from those in controls. This is intelligible on the Lyon hypothesis that, in women heterozygous for mutant genes on the X-chromosome, many cells will have as the active X-chromosome the one which carries the mutant gene.
Summary
Serum creatine kinase levels, using the method of Hughes, were measured on three separate occasions on 21 control women, 17 women heterozygous for the gene for severe sex-linked muscular dystrophy, five women and two girls heterozygous for the gene for the mild sex-linked form, and five women heterozygous for the gene for the autosomal recessive form. The mean level in the control women was 1.31 units (uM creatine per ml. serum per hour at 370 C.) and for the women heterozygous for the gene for severe sex-linked muscular dystrophy 4.02 units.
Using the logarithms of the enzyme levels to give more normal distributions the range for controls was 0.70 to 2.27 units and the range for heterozygotes for the gene for the sexlinked form was 1.50 to 8.93 units. About 90% of controls will have a mean level below 1.9 units and about 90 % of heterozygotes will have a mean level above 1.9 units. The distribution of the logarithms of the enzyme levels may be used in combination with the available genetic information to estimate the relative probability that a woman is or is not a heterozygote. For example, assuming normal distributions of the logarithms of the levels, below a level of 1.5 units the relative probability, from the enzyme level, was more than 10 to 1 that the woman was not a heterozygote; above 2.5 units it was more than 10 to 1 that the woman was a heterozygote.
In the small series of women heterozygous for the mild sexlinked and autosomal recessive forms the creatine kinase levels in the former did not differ significantly from those in the severe sex-linked form, and creatine kinase levels in the latter did not differ significantly from those in the controls. , 1965, 1, 753-756 There is no general agreement on the best form of medical treatment for peptic ulceration, although most people are prepared to consider the medical management of gastric and duodenal ulcers together as " peptic ulcer " in spite of the fact that their aetiology may be somewhat different (Dragstedt, 1962 ; Avery Jones, 1964) . It is accepted that the actual ulcer is caused by digestion of the mucosa by pepsin and hydrochloric acid, but the factors that allow this to happen are obscure. Excessive secretion of hydrochloric acid has been put forward as a likely cause, and it is partly on this basis that antacids are given in treatment. Other workers favour the idea that decreased tissue resistance is the basic cause of peptic ulcer and postulate many underlying factors influencing the decrease in resistance. Additional causes that have been given include excessive pepsin production, stress, hormonal dysfunction, and regurgitation of duodenal contents into the stomach (Spira, 1956 (Spira, , 1964 Sun, 1962; Dragstedt, 1962; Lancet, 1962) . In spite of this difference of opinion on aetiology, the most widely recommended form of therapy consists of modification D of diet, rest, and "antacids." The most frequently used of these are magnesium or bismuth salts. The rationale for using bismuth salts has been strengthened of recent years by the discovery that they have good antipepsin action without much acid-neutralizing power (Stephens, 1953 ; Bateson, 1954 Bateson, , 1958 . The importance of this has been increased by the American workers, who have shown that, in addition to pepsin, there may be several other acid proteases of gastric origin which will work at a higher pH (Hollander, 1962 ). These will not be influenced so much by neutralizing the gastric acidity.
Recent work has been carried out to test the validity of the hypothesis that pepsin-neutralization without much acidneutralization would be an effective form of treatment (Matts and Swan, 1964 Patients were then compared according to a random pairing pattern determined before the start of the trial, and the results, as regards advantage to one or other preparation, were plotted on a sequential analysis chart, which was based on a design suitable for small trials (Armitage, 1954 ; Snell and Armitage, 1957 ; Watkinson, 1958 ; Matts, 1960) . The advantages of using this design are that a significant result may emerge after a small number of patients have been included in the trial.
The specimens of gastric contents were analysed for both peptic activity and pH: pH was measured using a glass electrode. Aliquots of the gastric juices were adjusted to pH 2.01 and 3.65 with normal HC1 and/or N NaOH, and maintained at these two pH values with equal volumes of 0.1 M glycine and hydrochloric acid buffer pH 2.01 and with 0.2 M sodium acetate and hydrochloric acid buffer pH 3.65 respectively. Peptic activity was assayed on these adjusted samples by a modification of the method of Hunt (1948) .
In order to allow for possible incomplete aspiration of gastric contents at each analysis, the results were calculated as units per millilitre of gastric contents, and thus gave an estimate of the overall concentration of pepsin activity in the stomach contents at the time of analysis.
Results
The results were evaluated clinically and radiologically by the methods described. The two groups were then paired for sequential analysis by a predetermined randomized method and the results plotted on the prepared sequential analysis chart. From this can be seen a clear and statistically significant result in favour of the bismuth aluminate (see Graph), and the boundary of significance was reached after only six pairs of patients had been charted (the minimum number necessary).
The gastric analyses were carried out, and they were then examined for statistically significant changes, by comparing the means and the standard deviations of the various groups (see Table) . In no case was there any evidence of significant change, in either pH or pepsin activity, after administration of the drug; neither was there any evidence of a difference between the two groups. In fact, it appeared that treatment did not have a significant effect on the contents of the lumen of the stomach. This is in striking contrast to the marked clinical improvement obtained with bismuth aluminate.
Discussion
In considering and evaluating any method of treatment of peptic ulceration one is faced with a wide diversity of opinion on the underlying aetiology. This has led to many differing methods of treatment being used.
Antacid therapy is probably the most widely employed method in everyday clinical practice, and over 100 antacid preparations are in common use in Great Britain alone. However, much evidence has shown that they do not significantly change the gastric pH in vivo owing to inadequate dosage and rapid gastric emptying (Nicol, 1939 ; Sun, 1962 ; Schaub, 1963) . In spite of this fact antacid therapy does bring about symptomatic relief and its use is justified for this reason (Avery Peptic Ulceration-Matts et al. Jones, 1964 ; Kay, 1964) , although ulcer-healing has been shown to be unaffected even if the gastric pH is held above 4 throughout the 24 hours (Doll, Friedlander, and Pygott, 1956; Doll, Price, Pygott, and Sanderson, 1956 Fasting 4-1 + 2-1 31-0 21-3 10-5 10-3 lhourafter8g. gruel 2-7 + 16 30-9 11-6 10-7 4-1 lhourafter8g.gruel 2-6 + 15 31-7 16-6 9-1 + 6-1 12 hours after 8 g. gruel 3-4 ± 2 1 27 8 + 20-2 10-1 6-5
Fasting 4-4 ± 2-6 25-4 + 26-9 10-6 + 8-5 2 hour after 8 g. gruel 3-1 ± 1-9 33-3 + 18-2 10-9 6-6 1 hourafter8g. gruel 2 5 + 1-1 37-1 17-1 12-3 7-7 11 hours after 8 g. gruel 2 6 + 1-9 32-6 15-4 9-7 + 4-4 Bismuth Aluminate Group 5-8 + 1-8 29-4 26-2 11-3 + 10-0 4-1 2-7 27-7 + 22-9 7-9 after 6 g. gruel + antacid 3-2 + 1-6 32-7 16-1 9-9 7-2 3-3 + 2-0 23-7 17-9 8-9 after 6 g. gruel + i. antacid 3-3 1-4 42-8 + 8-2 17-5 7-1 4-1 + 2-5 28-6 20-1 9-2 after second 1-6 g. id 4-3 + 2-0 25-0 + 18-9 11-7 + 8-2 3-8 2-2 35-7 25-2 10-8
Magnesium Trisilicate Group Peptic Ulccration-Matts et al.
MEDICAL JOURNAL a striking improvement in patients with peptic ulceration follows their employment (Matts and Swan, 1964 ). An antisecretory agent (poldine) is recommended in treatment and shown to be of value (Douthwaite, 1958) , although later work shows it to have no effect in reducing the gastric acidity in duodenal-ulcer patients taking a bland diet (Lennard-Jones, 1961) . Other interesting therapeutic agents are carbenoxolone disodium salt (Biogastrone) and stilboestrol. Both have been subjected to carefully controlled clinical trials in pepsin ulceration and have been clearly shown to be valuable (Truelove, 1960; Doll, Hill, Hutton, and Underwood, 1962) , but the mode of action of each is not clear.
We would like to put forward the possibility of a local coating action as an explanation for the efficacy of bismuth aluminate in peptic ulceration, and consider that this might fit into current views on the causation of peptic ulcer by increasing the tissue-resistance component of the equation acid-pepsin versus the defensive powers of the mucosa. Certainly our in vivo gastric studies have thrown much doubt on whether the normal therapeutic dosage of either magnesium trisilicate or bismuth aluminate has any lasting or significant effect on the contents of the lumen of the stomach. In vivo, gastric analysis of the patients in the trial shows that neither agent has a significant effect on gastric pH or pepsin activity in the lumen of the stomach. The possibility of a local coating effect of bismuth is suggested as an explanation of its clinical efficacy.
In recent years advances in the diagnosis and surgical treatment of congenital and rheumatic heart disease have given greater importance to their early recognition. In addition, prophylactic treatment can be given against recurrences of rheumatic fever or the occurrence of bacterial endocarditis. Where the cardiac abnormality is an insignificant one an early authoritative explanation of this may avoid many unnecessary restrictions and possible cardiac neurosis.
Many different screening techniques for early diagnosis of heart disease have been pioneered, particularly in the United States of America. Mass miniature radiography has been used in many centres to help in the detection of heart disease, and is usually run in conjunction with a survey for lung diseases. The use and value of this method has been reported by West (1946 ), Flancher (1948 , Bostock and Morris (1952) , Porte (1952), and Schwartz and Berman (1952) .
Maclean and Rogen (1949) carried out a survey in Glasgow using 35 mm. chest x-ray films. They had the advantage of prior knowledge of either a history of rheumatic fever or of heart disease. Of 34,918 persons x-rayed, 1,703 were recalled and 220 of these were found to have heart disease. The knowledge of the history may account for the large number of recalls, but in some cases the history was found to be incorrect. Mathisen et al. (1950) , using 5 by 4-in. (12.5 by 10-cm.) chest x-ray films, reported on the detection of heart disease in a selected group-namely, patients referred by their physicians with suspected thoracic disease. Selzer et al. (1951) in their screening techniques used 35-mm. films. Suspected cases were recalled for fluoroscopic examination. If the cardiac outline was still thought to be abnormal these patients were recalled for investigation. This duplication seems unnecessary. Morton et al. (1959a) used 70-mm. chest x-ray films, lead V3R of the electrocardiogram, and physical examination by a team of 13 cardiologists. They discovered 33 cases of heart disease among 6,300 children examined and all but seven of these were congenital heart lesions. The method was laborious and expensive and would seem impracticable on a large scale. Morton et al. (1959b) compared three methods of screening schoolchildren: the single lead V3R electrocardiogram, a miniature chest x-ray film, and a limited physical examination. Their conclusions were that none of these methods alone was satisfactory and that the minimum basic examination still consisted of a full physical examination, chest x-ray film, and electrocardiogram.
